AI assistant
Lifecare ASA — Capital/Financing Update 2021
Nov 9, 2021
3654_rns_2021-11-09_6236a6c0-2853-4e01-b03a-3fce6b2a40f6.html
Capital/Financing Update
Open in viewerOpens in your device viewer
Lifecare – Share capital increase registered
Lifecare – Share capital increase registered
Bergen 9 November 2021
Reference is made to the announcement published on 5 October 2021 by Lifecare AS (the “Company”) regarding the issue of 15,467,834 new shares upon completion of a private placement of shares.
The share capital increase pertaining to the issuance of new shares under the private placement has now been registered with the Norwegian Register of Business Enterprises. The Company's new registered share capital is NOK 39,193,658.8 divided into 97,984,147 shares, each with a par value of NOK 0.4.
This is Lifecare
Lifecare is a Bergen-based technology company developing a miniaturized implantable long-term sensor for correct and continuous monitoring of blood sugar in people with diabetes. The Company's patented technology also has the potential for use in various biomarkers. Lifecare AS is listed on Euronext Growth (LIFE).
For further information, please contact:
Joacim Holter, CEO, Lifecare AS, [email protected], +47 40 05 90 40
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.This stock exchange announcement was published by Kine Hereid, Investor Relations at Lifecare AS, on 09.11.2021 at 09.00 CET.